Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1.
Dong H, Qiang Z, Chai D, Peng J, Xia Y, Hu R, Jiang H. · 2020
Read Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. by Dong H, Qiang Z, Chai D, Peng J, Xia Y, Hu R, Jiang H. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7377827.txt.
Introduction
Dong and co-authors study a form of cell death called ferroptosis in acute lung injury, in Aging. The injury model cuts blood flow to the gut and then restores it, which damages the lungs. Nrf2, a master regulator of the cell's antioxidant defenses, was their focus.
In injured lungs, markers showed the ferroptosis pattern: more lipid damage products, less glutathione, and less of the protective enzyme GPX4. Adding iron worsened the injury, while a ferroptosis blocker eased it. Silencing Nrf2 lowered two partner proteins, SLC7A11 and HO-1, and removing SLC7A11 strongly cut cell death in their models. Blocking this death route through Nrf2, they suggest, could become a treatment strategy.
Catalog record
| CREATOR | Dong H, Qiang Z, Chai D, Peng J, Xia Y, Hu R, Jiang H. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1 By Hui Dong, Zhuanzhuan Qiang, Dongdong Chai, Jiali Peng, Yangyang Xia, Rong Hu, Hong Jiang Published in: Aging (Albany NY) DOI: 10.18632/aging.103378 ABSTRACT Abstract Acute lung injury (ALI) is a syndrome associated with a high mortality rate. Nrf2 is a key regulator of intracellular oxidation homeostasis that plays a pivotal role in controlling lipid peroxidation, which is closely related to the process of ferroptosis. However, the intrinsic effect of Nrf2 on ferroptosis remains to be investigated in ALI. We found that MDA expression increased while GSH and GPX4 decreased in ALI models. Furthermore, the characteristic mitochondrial morphological changes of ferroptosis appear in type II alveolar epithelial cells in IIR models. Additional pre-treatment of Fe and Ferrostatin-1 in ALI significantly aggravated or ameliorated the pathological injuries of lung tissue, pulmonary edema, lipid peroxidation, as well as promoted or prevented cell death, respectively. Knocking down Nrf2 notably decreased the expression of SLC7A11 and HO-1. Interference with SLC7A11 markedly increased Nrf2-HO-1 and dramatically attenuated cell death in OGD/R models. These findings indicate that ferroptosis can be inhibited by Nrf2 through regulating SLC7A11 and HO-1, which may provide a potential therapeutic strategy for IIR-ALI. Keywords: ferroptosis, acute lung injury, solute carrier family 7 member 11, heme oxygenase-1, uclear factor erythroid 2 related factor2 INTRODUCTION Intestinal ischemia/reperfusion (IIR) injury is an intraoperative complication that can give rise to secondary vascular disease and a number of associated physiological conditions, which are predominantly related to the release of cytotoxic substances from ischemic tissues and inflammatory mediators [1]. As a consequence, IIR may lead to sepsis, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome [2]. Moreover, IIR has also been shown to cause acute lung injury (ALI), which in turn leads to a condition termed acute respiratory distress syndrome and contributes to the high mortality associated with IIR [3–5]. Thus, ALI caused by IIR is a challenging concern in the field of critical illness research [6]. Ferroptosis was initially reported in 2012 by Dixon et al [7, 8]. Ferroptosis can directly or indirectly inhibit glutathione peroxidase 4 (GPX4), which leads to intracellular antioxidant system damage and reactive oxygen species (ROS) accumulation in mitochondria, thereby causing cellular dysfunction [9, 10]. It was found that increasing cellular ferroptosis could further aggravate the functional damage to the viscera in models of renal and liver injury induced by ischemia-reperfusion [11, 12]. However, the molecular mechanism of ferroptosis in ALI following ischemia reperfusion has not yet been reported. Nuclear factor E2 related factor 2 (Nrf2) is the key regulatory factor required for cells to maintain an oxidative steady state and is activated under conditions of high oxidative stress. Nrf2 can then promote target gene transcription, as well as antioxidant and anti-inflammatory protein translation by combining to the antioxidant response element (ARE) in the nucleus, which promotes cellular protection [13]. Studies have previously reported that HO-1 plays a role in antioxidant protection under a state of high oxidative stress via control of the Nrf2/ARE pathway [14]. The SLC7A11 gene belongs to the solute transport family and encodes a cystine/glutamate xCT transporter, a key gene involved in regulating “iron overload-ferroptosis” [15]. In addition, Lin et al. [16] found that down-regulating SLC7A11 expression can result in decreased cystine-dependent glutathione peroxidase activity, cellular antioxidant capacity, lipid activity and oxygen elevation, which eventually causes cellular ferroptosis. In the present study, we investigated the features of ferroptosis in ALI following IIR and whether Nrf2 regulates ferroptosis and protects against ALI. To this end, we used C57BL/6 and Nrf2 gene knockout mice to establish an IIR-ALI model. The results clearly show that ferroptosis occurs in this model of ALI following IIR, and Nrf2 can regulate ferroptosis and protect against ALI. RESULTS Ferroptosis occurs in ALI due to IIR To first verify the reliability of the model, we established that the level of pulmonary tissue oedema gradually worsened with prolonged IIR time (Figure 1A). We next explored the role of ferroptosis in the IIR-ALI model. Using transmission electron microscopy, we observed that compared with the sham group, the mitochondrial morphology in type II alveolar epithelial cells of mice in the IIR group showed the characteristic changes of ferroptosis, including the presence of smaller mitochondria and reduced cristae (Figure 1B). Through HE staining of pathological sections (Figure 1C) and W/D experiments (Figure 1E), we found that after IIR, the extent of lung tissue damage was aggravated, and the degree of pulmonary oedema had increased (P < 0.05). In addition, the lipid peroxide MDA (Figure 1F) increased while the reduced glutathione (GSH) (Figure 1G) decreased, which are characteristic indicators of ferroptosis. To this end, we injected Fe (a promoter of ferroptosis) and ferrostatin-1 (Fer-1, a specific ferroptosis inhibitor) into the tail veins of mice. The lung tissue was collected from the mice after completing the experiment. Pathological HE staining (Figure 1C) and the wet to dry ratios of the lung tissues (Figure 1E) showed a larger area of inflammatory cell infiltration in the alveoli or more severe pulmonary oedema following the addition of Fe. In addition, the extent of the injury was reduced compared with the IIR group following Fer-1 administration. Similarly, the level of MDA (Figure 1F) was further increased or decreased with the application of Fe or ferrostatin-1 respectively compared to the IIR group; however, the opposite was observed with the level of GSH (Figure 1G). These are all characteristic indicators of ferroptosis. Therefore, these findings suggest that ferroptosis occurred in IIR-ALI. [Figure: IIR induces ferroptosis in type II alveolar epithelial cells. (A) The degree of pulmonary oedema continued to increase with the extension of reperfusion time. (B) Representative transmission electron micrographs of the ultrastructure of lung tissues. Scale bars: 1 μm. (C) HE staining of the lung tissues of mice following IIR, IIR + Fe, and IIR + Fer-1. Scale bars: 200 μm. (D) The lung pathological damage score showed an addition and reduction after Fe and Fer-1 administration, respectively. (E) The wet to dry ratio of the lung tissue shown in each group. (F) The level of lipid peroxide MDA in each group. (G) The GSH level in each group. The error bars represent the standard error from three replicates. Data are presented as the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 between the groups; *compared with the sham group; # compared with the IIR group.] The Nrf2-SLC7A11/HO-1 pathway can inhibit ferroptosis and play a protective role in IIR-ALI Following IIR-ALI, the transcriptional activity of Nrf2 increased, and cytoplasmic Nrf2 was transferred into the nucleus. The level of total Nrf2, SLC7A11, and HO-1 protein expression was enhanced, whereas the expression of the GPX4 was reduced. The first three proteins displayed enhanced severity following the administration of Fe. However, the level of protein expression was reduced compared with that of the OGD/R group following the administration of Fer-1. In contrast, the level of GPX4 protein expression could be increased by Fer-1 administration. (Figure 2A). The RT-PCR results were consistent with the Western blot (WB) analysis (Figure 2C). We used Nrf2 gene knockout mice to further explore the role of Nrf2 in ferroptosis and IIR-ALI. The